ArticleJournal of clinical and translational science2026
Explainable machine learning for predicting coronary heart disease risk in patients with carotid atherosclerosis: A retrospective study with SHAP and decision curve analysis.
Article in Journal of clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and validation of an interpretable machine learning model for predicting atrial fibrillation risk in middle-aged and older patients with coronary heart disease.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Carotid atherosclerosis is associated with increased coronary heart disease (CHD) risk, yet current risk models lack specificity and interpretability for this population. This study aimed to develop explainable machine learning (ML) models to predict CHD in these patients. Methods: We retrospectively analyzed 487 patients with carotid atherosclerosis (191 CHD, 296 non-CHD) from January 2022 to July 2025. Thirty-eight variables were collected, including demographic, clinical, and biochemical indicators. LASSO regression identified six key predictors. Seven ML models were trained and evaluated using area under receiver operating characteristic curve (AUC), PRC-AUC, calibration curves, and decision curve analysis (DCA). SHAP was applied to interpret the best-performing model. Results: Logistic regression model achieved the highest test-set performance (AUC = 0.827; PRC-AUC = 0.752), with strong generalizability and calibration. SHAP analysis identified age and diastolic blood pressure as the most influential features, aligning with model coefficients. DCA demonstrated superior clinical net benefit of the logistic regression model across probability thresholds. Conclusion: A six-variable logistic model provides accurate and interpretable CHD risk prediction in patients with carotid atherosclerosis. Its transparency and clinical utility support its integration into personalized risk management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.